CM Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-45,000
Closed -$1.16M 75
2025
Q2
$1.16M Sell
45,000
-8,333
-16% -$93.6K 1.06% 33
2025
Q1
$544K Buy
53,333
+3,333
+7% +$43.5K 0.55% 44
2024
Q4
$698K Hold
50,000
0.62% 45
2024
Q3
$975K Hold
50,000
0.78% 46
2024
Q2
$930K Sell
50,000
-12,656
-20% -$267K 0.85% 42
2024
Q1
$878K Hold
62,656
0.74% 45
2023
Q4
$531K Buy
62,656
+9,323
+17% +$70.6K 0.43% 54
2023
Q3
$476K Buy
53,333
+3,333
+7% +$32.1K 0.51% 48
2023
Q2
$431K Buy
50,000
+23,333
+87% +$249K 0.42% 55
2023
Q1
$281K Buy
26,667
+18,334
+220% +$555K 0.33% 54
2022
Q4
$283K Buy
8,333
+5,000
+150% +$242K 0.34% 60
2022
Q3
$160K Sell
3,333
-5,000
-60% -$297K 0.18% 71
2022
Q2
$475K Buy
8,333
+3,333
+67% +$210K 0.51% 57
2022
Q1
$404K Buy
5,000
+3,333
+200% +$493K 0.34% 69
2021
Q4
$338K Sell
1,667
-1,666
-50% -$361K 0.26% 79
2021
Q3
$898K Hold
3,333
0.67% 56
2021
Q2
$858K Hold
3,333
0.62% 58
2021
Q1
$1M Buy
3,333
+1,000
+43% +$311K 0.74% 57
2020
Q4
$595K Buy
+2,333
New +$603K 0.55% 56

Other funds holding NKTR